Timothy Sullivan - Jan 22, 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Financial Officer
Signature
/s/s David Watson, attorney-in-fact for Timothy Sullivan
Stock symbol
APLS
Transactions as of
Jan 22, 2024
Transactions value $
-$230,801
Form type
4
Date filed
1/23/2024, 06:13 PM
Previous filing
Jan 17, 2024
Next filing
Jan 31, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$231K -3.55K -3.58% $65.00 95.7K Jan 22, 2024 Direct F1
holding APLS Common Stock 56.2K Jan 22, 2024 The Timothy E Sullivan Irrevocable Trust of 2023 F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/19/2024.
F2 The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.